{"id":"https://openalex.org/W68282923","doi":"https://doi.org/10.1056/nejm199801153380304","title":"Interleukin-2\u2013Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation","display_name":"Interleukin-2\u2013Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation","publication_year":1998,"publication_date":"1998-01-15","ids":{"openalex":"https://openalex.org/W68282923","doi":"https://doi.org/10.1056/nejm199801153380304","mag":"68282923","pmid":"https://pubmed.ncbi.nlm.nih.gov/9428817"},"language":"en","primary_location":{"id":"doi:10.1056/nejm199801153380304","doi":"https://doi.org/10.1056/nejm199801153380304","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejm199801153380304","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199801153380304?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199801153380304?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006314209","display_name":"Flavio Vincenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Flavio Vincenti","raw_affiliation_strings":["University of California, San Francisco 94143-0116, USA","University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco 94143-0116, USA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068487647","display_name":"Robert L. Kirkman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Kirkman","raw_affiliation_strings":["Brigham and Women's Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077662405","display_name":"Susan E. Light","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Light","raw_affiliation_strings":["Hoffmann\u2013LaRoche, Nutley, N.J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann\u2013LaRoche, Nutley, N.J","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007122777","display_name":"Ginny L. Bumgardner","orcid":"https://orcid.org/0000-0002-3256-0200","observed_orcids":["https://orcid.org/0000-0002-3256-0200"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ginny Bumgardner","raw_affiliation_strings":["Ohio State University, Columbus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University, Columbus","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042236941","display_name":"Mark D. Pescovitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Pescovitz","raw_affiliation_strings":["Indiana University, Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072478271","display_name":"Philip F. Halloran","orcid":"https://orcid.org/0000-0003-1371-1947","observed_orcids":["https://orcid.org/0000-0003-1371-1947"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Philip Halloran","raw_affiliation_strings":["University of Alberta, Edmonton, Alta., Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alta., Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108753108","display_name":"John F. Neylan","orcid":"https://orcid.org/0000-0001-6573-8143","observed_orcids":["https://orcid.org/0000-0001-6573-8143"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Neylan","raw_affiliation_strings":["Emory University, Atlanta"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017078172","display_name":"Alan H. Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Wilkinson","raw_affiliation_strings":["University of California, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045536800","display_name":"Henrik Ekberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henrik Ekberg","raw_affiliation_strings":["Malm\u00f6 University Hospital, Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malm\u00f6 University Hospital, Malm\u00f6, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017765749","display_name":"Robert S. Gaston","orcid":"https://orcid.org/0009-0001-1642-3038","observed_orcids":["https://orcid.org/0009-0001-1642-3038"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Gaston","raw_affiliation_strings":["University of Alabama, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama, Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051550363","display_name":"Lars B\u00e4ckman","orcid":"https://orcid.org/0000-0002-4312-7357","observed_orcids":["https://orcid.org/0000-0002-4312-7357"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lars Backman","raw_affiliation_strings":["Sahlgrenska Hospital, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska Hospital, Gothenburg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109145662","display_name":"James F. Burdick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Burdick","raw_affiliation_strings":["Johns Hopkins University, Baltimore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":65.6353,"has_fulltext":true,"cited_by_count":864,"citation_normalized_percentile":{"value":1.0,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"338","issue":"3","first_page":"161","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daclizumab","display_name":"daclizumab","score":1.0},{"id":"https://openalex.org/keywords/interleukin-2-receptor-blockade","display_name":"interleukin-2 receptor blockade","score":0.9449999928474426},{"id":"https://openalex.org/keywords/acute-rejection","display_name":"acute rejection","score":0.8820000290870667},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.753000020980835},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7440000176429749},{"id":"https://openalex.org/keywords/graft-survival","display_name":"graft survival","score":0.718999981880188},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.8619999885559082},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.968999981880188},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.8619999885559082},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C2779719350","wikidata":"https://www.wikidata.org/wiki/Q412920","display_name":"Daclizumab","level":4,"score":0.9880619645118713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9128628969192505},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6623431444168091},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.5667909383773804},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.5059928297996521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48048272728919983},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46754899621009827},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.45009666681289673},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.42667335271835327},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37665918469429016},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.14031735062599182},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1294519305229187},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077561","descriptor_name":"Daclizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077561","descriptor_name":"Daclizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077561","descriptor_name":"Daclizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejm199801153380304","doi":"https://doi.org/10.1056/nejm199801153380304","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejm199801153380304","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199801153380304?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:9428817","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9428817","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1056/nejm199801153380304","doi":"https://doi.org/10.1056/nejm199801153380304","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejm199801153380304","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199801153380304?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8500000238418579,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W68282923.pdf","grobid_xml":"https://content.openalex.org/works/W68282923.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W50336179","https://openalex.org/W1934038313","https://openalex.org/W1964210645","https://openalex.org/W1996431651","https://openalex.org/W2000988825","https://openalex.org/W2006336823","https://openalex.org/W2019306593","https://openalex.org/W2042336731","https://openalex.org/W2052150715","https://openalex.org/W2060516601","https://openalex.org/W2071112640","https://openalex.org/W2071648784","https://openalex.org/W2076597593","https://openalex.org/W2165929916","https://openalex.org/W2280027108","https://openalex.org/W2332754031","https://openalex.org/W2415268213","https://openalex.org/W2462154752"],"related_works":["https://openalex.org/W2065729608","https://openalex.org/W2917955192","https://openalex.org/W2058692801","https://openalex.org/W2010701367","https://openalex.org/W60844075","https://openalex.org/W2436730684","https://openalex.org/W2048438191","https://openalex.org/W2410325363","https://openalex.org/W2056932738","https://openalex.org/W1989013906"],"abstract_inverted_index":{"BACKGROUND:":[0],"Monoclonal":[1],"antibodies":[2],"that":[3,27],"block":[4],"the":[5,31,35,42,108,121,140,158,167,183,195,229],"high-affinity":[6],"interleukin-2":[7,36],"receptor":[8,37],"expressed":[9],"on":[10,223],"alloantigen-reactive":[11],"T":[12],"lymphocytes":[13],"may":[14,39],"cause":[15],"selective":[16],"immunosuppression.":[17],"Daclizumab":[18,227],"is":[19],"a":[20,72],"genetically":[21],"engineered":[22],"human":[23],"IgG1":[24],"monoclonal":[25],"antibody":[26],"binds":[28],"specifically":[29],"to":[30,77,182,200],"alpha":[32],"chain":[33],"of":[34,44,57,74,110,132,139,208,220,231],"and":[38,65,85,91,185,213],"thus":[40],"reduce":[41],"risk":[43],"rejection":[45,113,233],"after":[46,117],"renal":[47],"transplantation.":[48,118],"METHODS:":[49],"We":[50],"administered":[51],"daclizumab":[52,175,209],"(1.0":[53],"mg":[54],"per":[55],"kilogram":[56],"body":[58],"weight)":[59],"or":[60,203],"placebo":[61,147,170],"intravenously":[62],"before":[63],"transplantation":[64],"once":[66],"every":[67],"other":[68],"week":[69],"afterward,":[70],"for":[71,100],"total":[73],"five":[75],"doses,":[76],"260":[78],"patients":[79,94,123,142,168,173],"receiving":[80],"first":[81],"cadaveric":[82],"kidney":[83],"grafts":[84],"immunosuppressive":[86],"therapy":[87],"with":[88,137,163,198],"cyclosporine,":[89],"azathioprine,":[90],"prednisone.":[92],"The":[93,103,172,205],"were":[95,190],"followed":[96],"at":[97,151,186],"regular":[98],"intervals":[99],"12":[101,152],"months.":[102],"primary":[104],"end":[105],"point":[106],"was":[107,154,210],"incidence":[109],"biopsy-confirmed":[111,130],"acute":[112,133,232],"within":[114],"six":[115,187],"months":[116,153],"RESULTS:":[119],"Of":[120],"126":[122],"given":[124,169,174],"daclizumab,":[125],"28":[126],"(22":[127],"percent)":[128,144],"had":[129],"episodes":[131],"rejection,":[134],"as":[135,161],"compared":[136,162],"47":[138],"134":[141],"(35":[143],"who":[145],"received":[146],"(P=0.03).":[148],"Graft":[149],"survival":[150],"95":[155],"percent":[156,165],"in":[157,166,217,234],"daclizumab-treated":[159],"patients,":[160],"90":[164],"(P=0.08).":[171],"did":[176],"not":[177],"have":[178],"any":[179],"adverse":[180],"reactions":[181],"drug,":[184],"months,":[188],"there":[189],"no":[191],"significant":[192],"differences":[193],"between":[194],"two":[196],"groups":[197],"respect":[199],"infectious":[201],"complications":[202],"cancers.":[204],"serum":[206],"half-life":[207],"20":[211],"days,":[212],"its":[214],"administration":[215],"resulted":[216],"prolonged":[218],"saturation":[219],"interleukin-2alpha":[221],"receptors":[222],"circulating":[224],"lymphocytes.":[225],"CONCLUSIONS:":[226],"reduces":[228],"frequency":[230],"kidney-transplant":[235],"recipients.":[236]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":20}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}